Cidara Therapeutics Inc.

04/14/2022 | Press release | Distributed by Public on 04/14/2022 06:06

Cidara Therapeutics and Mundipharma to Present Results from Global Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and/or Invasive Candidiasis at ECCMID 2022